Click for best price
Biosimilars Market Size, Share 2022
A biosimilar is a biologic medical product highly similar to another already approved biological medicine (the 'reference medicine'). Biosimilars are approved according to the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. Biosimilars are officially approved versions of original "innovator" products and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
This report contains market size and forecasts of Biosimilars in global, including the following market information:
Global top five Biosimilars companies in 2021 (%)
The global Biosimilars market was valued at 5893.3 million in 2021 and is projected to reach US$ 17930 million by 2028, at a CAGR of 17.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biosimilars include Pfizer, Novartis, Biocon, Biogen, Fresenius Kabi AG, Boehringer Ingelheim, Merck KgaA, Mylan and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilars Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Biosimilars Market Segment Percentages, by Type, 2021 (%)
- Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
- Recombinant Glycosylated Proteins
Global Biosimilars Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Biosimilars Market Segment Percentages, by Application, 2021 (%)
- Oncology
- Blood Disorders
- Growth Hormonal Deficiency
- Chronic and Autoimmune Disorders
- Others
Global Biosimilars Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Biosimilars Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biosimilars revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Biosimilars revenues share in global market, 2021 (%)
- Key companies Biosimilars sales in global market, 2017-2022 (Estimated), (K MT)
- Key companies Biosimilars sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Novartis
- Biocon
- Biogen
- Fresenius Kabi AG
- Boehringer Ingelheim
- Merck KgaA
- Mylan
- Eli Lilly
- Teva Pharmaceutical
- Dr. Reddy's Laboratories
- Amgen
- Celltrion
- Samsung Biologics
- Roche
- Probiomed
- Apotex
- Chong Kun Dang
- JCR Pharmaceuticals
- Gan & Lee Pharmaceuticals
- Gedeon Richter
- Biocad
- Coherus Bioscience
- Stada Arzneimittel AG
| Report Attributes |
Report Details |
| Report Title |
Biosimilars Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
126 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biosimilars Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilars Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilars Overall Market Size
2.1 Global Biosimilars Market Size: 2021 VS 2028
2.2 Global Biosimilars Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Biosimilars Sales: 2017-2028
3 Company Landscape
3.1 Top Biosimilars Players in Global Market
3.2 Top Global Biosimilars Companies Ranked by Revenue
3.3 Global Biosimilars Revenue by Companies
3.4 Global Biosimilars Sales by Companies
3.5 Global Biosimilars Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Biosimilars Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Biosimilars Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biosimilars Players in Global Market
3.8.1 List of Global Tier 1 Biosimilars Companies
3.8.2 List of Global Tier 2 and Tier 3 Biosimilars Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biosimilars Market Size Markets, 2021 & 2028
4.1.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
4.1.3 Recombinant Glycosylated Proteins
4.2 By Type - Global Biosimilars Revenue & Forecasts
4.2.1 By Type - Global Biosimilars Revenue, 2017-2022
4.2.2 By Type - Global Biosimilars Revenue, 2023-2028
4.2.3 By Type - Global Biosimilars Revenue Market Share, 2017-2028
4.3 By Type - Global Biosimilars Sales & Forecasts
4.3.1 By Type - Global Biosimilars Sales, 2017-2022
4.3.2 By Type - Global Biosimilars Sales, 2023-2028
4.3.3 By Type - Global Biosimilars Sales Market Share, 2017-2028
4.4 By Type - Global Biosimilars Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Biosimilars Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Blood Disorders
5.1.4 Growth Hormonal Deficiency
5.1.5 Chronic and Autoimmune Disorders
5.1.6 Others
5.2 By Application - Global Biosimilars Revenue & Forecasts
5.2.1 By Application - Global Biosimilars Revenue, 2017-2022
5.2.2 By Application - Global Biosimilars Revenue, 2023-2028
5.2.3 By Application - Global Biosimilars Revenue Market Share, 2017-2028
5.3 By Application - Global Biosimilars Sales & Forecasts
5.3.1 By Application - Global Biosimilars Sales, 2017-2022
5.3.2 By Application - Global Biosimilars Sales, 2023-2028
5.3.3 By Application - Global Biosimilars Sales Market Share, 2017-2028
5.4 By Application - Global Biosimilars Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Biosimilars Market Size, 2021 & 2028
6.2 By Region - Global Biosimilars Revenue & Forecasts
6.2.1 By Region - Global Biosimilars Revenue, 2017-2022
6.2.2 By Region - Global Biosimilars Revenue, 2023-2028
6.2.3 By Region - Global Biosimilars Revenue Market Share, 2017-2028
6.3 By Region - Global Biosimilars Sales & Forecasts
6.3.1 By Region - Global Biosimilars Sales, 2017-2022
6.3.2 By Region - Global Biosimilars Sales, 2023-2028
6.3.3 By Region - Global Biosimilars Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Biosimilars Revenue, 2017-2028
6.4.2 By Country - North America Biosimilars Sales, 2017-2028
6.4.3 US Biosimilars Market Size, 2017-2028
6.4.4 Canada Biosimilars Market Size, 2017-2028
6.4.5 Mexico Biosimilars Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Biosimilars Revenue, 2017-2028
6.5.2 By Country - Europe Biosimilars Sales, 2017-2028
6.5.3 Germany Biosimilars Market Size, 2017-2028
6.5.4 France Biosimilars Market Size, 2017-2028
6.5.5 U.K. Biosimilars Market Size, 2017-2028
6.5.6 Italy Biosimilars Market Size, 2017-2028
6.5.7 Russia Biosimilars Market Size, 2017-2028
6.5.8 Nordic Countries Biosimilars Market Size, 2017-2028
6.5.9 Benelux Biosimilars Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Biosimilars Revenue, 2017-2028
6.6.2 By Region - Asia Biosimilars Sales, 2017-2028
6.6.3 China Biosimilars Market Size, 2017-2028
6.6.4 Japan Biosimilars Market Size, 2017-2028
6.6.5 South Korea Biosimilars Market Size, 2017-2028
6.6.6 Southeast Asia Biosimilars Market Size, 2017-2028
6.6.7 India Biosimilars Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Biosimilars Revenue, 2017-2028
6.7.2 By Country - South America Biosimilars Sales, 2017-2028
6.7.3 Brazil Biosimilars Market Size, 2017-2028
6.7.4 Argentina Biosimilars Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biosimilars Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Biosimilars Sales, 2017-2028
6.8.3 Turkey Biosimilars Market Size, 2017-2028
6.8.4 Israel Biosimilars Market Size, 2017-2028
6.8.5 Saudi Arabia Biosimilars Market Size, 2017-2028
6.8.6 UAE Biosimilars Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Biosimilars Major Product Offerings
7.1.4 Pfizer Biosimilars Sales and Revenue in Global (2017-2022)
7.1.5 Pfizer Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Biosimilars Major Product Offerings
7.2.4 Novartis Biosimilars Sales and Revenue in Global (2017-2022)
7.2.5 Novartis Key News
7.3 Biocon
7.3.1 Biocon Corporate Summary
7.3.2 Biocon Business Overview
7.3.3 Biocon Biosimilars Major Product Offerings
7.3.4 Biocon Biosimilars Sales and Revenue in Global (2017-2022)
7.3.5 Biocon Key News
7.4 Biogen
7.4.1 Biogen Corporate Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen Biosimilars Major Product Offerings
7.4.4 Biogen Biosimilars Sales and Revenue in Global (2017-2022)
7.4.5 Biogen Key News
7.5 Fresenius Kabi AG
7.5.1 Fresenius Kabi AG Corporate Summary
7.5.2 Fresenius Kabi AG Business Overview
7.5.3 Fresenius Kabi AG Biosimilars Major Product Offerings
7.5.4 Fresenius Kabi AG Biosimilars Sales and Revenue in Global (2017-2022)
7.5.5 Fresenius Kabi AG Key News
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Corporate Summary
7.6.2 Boehringer Ingelheim Business Overview
7.6.3 Boehringer Ingelheim Biosimilars Major Product Offerings
7.6.4 Boehringer Ingelheim Biosimilars Sales and Revenue in Global (2017-2022)
7.6.5 Boehringer Ingelheim Key News
7.7 Merck KgaA
7.7.1 Merck KgaA Corporate Summary
7.7.2 Merck KgaA Business Overview
7.7.3 Merck KgaA Biosimilars Major Product Offerings
7.7.4 Merck KgaA Biosimilars Sales and Revenue in Global (2017-2022)
7.7.5 Merck KgaA Key News
7.8 Mylan
7.8.1 Mylan Corporate Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Biosimilars Major Product Offerings
7.8.4 Mylan Biosimilars Sales and Revenue in Global (2017-2022)
7.8.5 Mylan Key News
7.9 Eli Lilly
7.9.1 Eli Lilly Corporate Summary
7.9.2 Eli Lilly Business Overview
7.9.3 Eli Lilly Biosimilars Major Product Offerings
7.9.4 Eli Lilly Biosimilars Sales and Revenue in Global (2017-2022)
7.9.5 Eli Lilly Key News
7.10 Teva Pharmaceutical
7.10.1 Teva Pharmaceutical Corporate Summary
7.10.2 Teva Pharmaceutical Business Overview
7.10.3 Teva Pharmaceutical Biosimilars Major Product Offerings
7.10.4 Teva Pharmaceutical Biosimilars Sales and Revenue in Global (2017-2022)
7.10.5 Teva Pharmaceutical Key News
7.11 Dr. Reddy's Laboratories
7.11.1 Dr. Reddy's Laboratories Corporate Summary
7.11.2 Dr. Reddy's Laboratories Biosimilars Business Overview
7.11.3 Dr. Reddy's Laboratories Biosimilars Major Product Offerings
7.11.4 Dr. Reddy's Laboratories Biosimilars Sales and Revenue in Global (2017-2022)
7.11.5 Dr. Reddy's Laboratories Key News
7.12 Amgen
7.12.1 Amgen Corporate Summary
7.12.2 Amgen Biosimilars Business Overview
7.12.3 Amgen Biosimilars Major Product Offerings
7.12.4 Amgen Biosimilars Sales and Revenue in Global (2017-2022)
7.12.5 Amgen Key News
7.13 Celltrion
7.13.1 Celltrion Corporate Summary
7.13.2 Celltrion Biosimilars Business Overview
7.13.3 Celltrion Biosimilars Major Product Offerings
7.13.4 Celltrion Biosimilars Sales and Revenue in Global (2017-2022)
7.13.5 Celltrion Key News
7.14 Samsung Biologics
7.14.1 Samsung Biologics Corporate Summary
7.14.2 Samsung Biologics Business Overview
7.14.3 Samsung Biologics Biosimilars Major Product Offerings
7.14.4 Samsung Biologics Biosimilars Sales and Revenue in Global (2017-2022)
7.14.5 Samsung Biologics Key News
7.15 Roche
7.15.1 Roche Corporate Summary
7.15.2 Roche Business Overview
7.15.3 Roche Biosimilars Major Product Offerings
7.15.4 Roche Biosimilars Sales and Revenue in Global (2017-2022)
7.15.5 Roche Key News
7.16 Probiomed
7.16.1 Probiomed Corporate Summary
7.16.2 Probiomed Business Overview
7.16.3 Probiomed Biosimilars Major Product Offerings
7.16.4 Probiomed Biosimilars Sales and Revenue in Global (2017-2022)
7.16.5 Probiomed Key News
7.17 Apotex
7.17.1 Apotex Corporate Summary
7.17.2 Apotex Business Overview
7.17.3 Apotex Biosimilars Major Product Offerings
7.17.4 Apotex Biosimilars Sales and Revenue in Global (2017-2022)
7.17.5 Apotex Key News
7.18 Chong Kun Dang
7.18.1 Chong Kun Dang Corporate Summary
7.18.2 Chong Kun Dang Business Overview
7.18.3 Chong Kun Dang Biosimilars Major Product Offerings
7.18.4 Chong Kun Dang Biosimilars Sales and Revenue in Global (2017-2022)
7.18.5 Chong Kun Dang Key News
7.19 JCR Pharmaceuticals
7.19.1 JCR Pharmaceuticals Corporate Summary
7.19.2 JCR Pharmaceuticals Business Overview
7.19.3 JCR Pharmaceuticals Biosimilars Major Product Offerings
7.19.4 JCR Pharmaceuticals Biosimilars Sales and Revenue in Global (2017-2022)
7.19.5 JCR Pharmaceuticals Key News
7.20 Gan & Lee Pharmaceuticals
7.20.1 Gan & Lee Pharmaceuticals Corporate Summary
7.20.2 Gan & Lee Pharmaceuticals Business Overview
7.20.3 Gan & Lee Pharmaceuticals Biosimilars Major Product Offerings
7.20.4 Gan & Lee Pharmaceuticals Biosimilars Sales and Revenue in Global (2017-2022)
7.20.5 Gan & Lee Pharmaceuticals Key News
7.21 Gedeon Richter
7.21.1 Gedeon Richter Corporate Summary
7.21.2 Gedeon Richter Business Overview
7.21.3 Gedeon Richter Biosimilars Major Product Offerings
7.21.4 Gedeon Richter Biosimilars Sales and Revenue in Global (2017-2022)
7.21.5 Gedeon Richter Key News
7.22 Biocad
7.22.1 Biocad Corporate Summary
7.22.2 Biocad Business Overview
7.22.3 Biocad Biosimilars Major Product Offerings
7.22.4 Biocad Biosimilars Sales and Revenue in Global (2017-2022)
7.22.5 Biocad Key News
7.23 Coherus Bioscience
7.23.1 Coherus Bioscience Corporate Summary
7.23.2 Coherus Bioscience Business Overview
7.23.3 Coherus Bioscience Biosimilars Major Product Offerings
7.23.4 Coherus Bioscience Biosimilars Sales and Revenue in Global (2017-2022)
7.23.5 Coherus Bioscience Key News
7.24 Stada Arzneimittel AG
7.24.1 Stada Arzneimittel AG Corporate Summary
7.24.2 Stada Arzneimittel AG Business Overview
7.24.3 Stada Arzneimittel AG Biosimilars Major Product Offerings
7.24.4 Stada Arzneimittel AG Biosimilars Sales and Revenue in Global (2017-2022)
7.24.5 Stada Arzneimittel AG Key News
8 Global Biosimilars Production Capacity, Analysis
8.1 Global Biosimilars Production Capacity, 2017-2028
8.2 Biosimilars Production Capacity of Key Manufacturers in Global Market
8.3 Global Biosimilars Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biosimilars Supply Chain Analysis
10.1 Biosimilars Industry Value Chain
10.2 Biosimilars Upstream Market
10.3 Biosimilars Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biosimilars Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Biosimilars in Global Market
Table 2. Top Biosimilars Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Biosimilars Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Biosimilars Revenue Share by Companies, 2017-2022
Table 5. Global Biosimilars Sales by Companies, (K MT), 2017-2022
Table 6. Global Biosimilars Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Biosimilars Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Biosimilars Product Type
Table 9. List of Global Tier 1 Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilars Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Biosimilars Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Biosimilars Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Biosimilars Sales (K MT), 2017-2022
Table 15. By Type - Global Biosimilars Sales (K MT), 2023-2028
Table 16. By Application ? Global Biosimilars Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Biosimilars Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Biosimilars Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Biosimilars Sales (K MT), 2017-2022
Table 20. By Application - Global Biosimilars Sales (K MT), 2023-2028
Table 21. By Region ? Global Biosimilars Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Biosimilars Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Biosimilars Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Biosimilars Sales (K MT), 2017-2022
Table 25. By Region - Global Biosimilars Sales (K MT), 2023-2028
Table 26. By Country - North America Biosimilars Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Biosimilars Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Biosimilars Sales, (K MT), 2017-2022
Table 29. By Country - North America Biosimilars Sales, (K MT), 2023-2028
Table 30. By Country - Europe Biosimilars Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Biosimilars Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Biosimilars Sales, (K MT), 2017-2022
Table 33. By Country - Europe Biosimilars Sales, (K MT), 2023-2028
Table 34. By Region - Asia Biosimilars Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Biosimilars Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Biosimilars Sales, (K MT), 2017-2022
Table 37. By Region - Asia Biosimilars Sales, (K MT), 2023-2028
Table 38. By Country - South America Biosimilars Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Biosimilars Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Biosimilars Sales, (K MT), 2017-2022
Table 41. By Country - South America Biosimilars Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Biosimilars Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Biosimilars Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Biosimilars Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Biosimilars Sales, (K MT), 2023-2028
Table 46. Pfizer Corporate Summary
Table 47. Pfizer Biosimilars Product Offerings
Table 48. Pfizer Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Novartis Corporate Summary
Table 50. Novartis Biosimilars Product Offerings
Table 51. Novartis Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Biocon Corporate Summary
Table 53. Biocon Biosimilars Product Offerings
Table 54. Biocon Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Biogen Corporate Summary
Table 56. Biogen Biosimilars Product Offerings
Table 57. Biogen Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Fresenius Kabi AG Corporate Summary
Table 59. Fresenius Kabi AG Biosimilars Product Offerings
Table 60. Fresenius Kabi AG Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Boehringer Ingelheim Corporate Summary
Table 62. Boehringer Ingelheim Biosimilars Product Offerings
Table 63. Boehringer Ingelheim Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Merck KgaA Corporate Summary
Table 65. Merck KgaA Biosimilars Product Offerings
Table 66. Merck KgaA Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Mylan Corporate Summary
Table 68. Mylan Biosimilars Product Offerings
Table 69. Mylan Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Eli Lilly Corporate Summary
Table 71. Eli Lilly Biosimilars Product Offerings
Table 72. Eli Lilly Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Teva Pharmaceutical Corporate Summary
Table 74. Teva Pharmaceutical Biosimilars Product Offerings
Table 75. Teva Pharmaceutical Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 76. Dr. Reddy's Laboratories Corporate Summary
Table 77. Dr. Reddy's Laboratories Biosimilars Product Offerings
Table 78. Dr. Reddy's Laboratories Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 79. Amgen Corporate Summary
Table 80. Amgen Biosimilars Product Offerings
Table 81. Amgen Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 82. Celltrion Corporate Summary
Table 83. Celltrion Biosimilars Product Offerings
Table 84. Celltrion Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 85. Samsung Biologics Corporate Summary
Table 86. Samsung Biologics Biosimilars Product Offerings
Table 87. Samsung Biologics Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 88. Roche Corporate Summary
Table 89. Roche Biosimilars Product Offerings
Table 90. Roche Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 91. Probiomed Corporate Summary
Table 92. Probiomed Biosimilars Product Offerings
Table 93. Probiomed Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 94. Apotex Corporate Summary
Table 95. Apotex Biosimilars Product Offerings
Table 96. Apotex Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 97. Chong Kun Dang Corporate Summary
Table 98. Chong Kun Dang Biosimilars Product Offerings
Table 99. Chong Kun Dang Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 100. JCR Pharmaceuticals Corporate Summary
Table 101. JCR Pharmaceuticals Biosimilars Product Offerings
Table 102. JCR Pharmaceuticals Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 103. Gan & Lee Pharmaceuticals Corporate Summary
Table 104. Gan & Lee Pharmaceuticals Biosimilars Product Offerings
Table 105. Gan & Lee Pharmaceuticals Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 106. Gedeon Richter Corporate Summary
Table 107. Gedeon Richter Biosimilars Product Offerings
Table 108. Gedeon Richter Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 109. Biocad Corporate Summary
Table 110. Biocad Biosimilars Product Offerings
Table 111. Biocad Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 112. Coherus Bioscience Corporate Summary
Table 113. Coherus Bioscience Biosimilars Product Offerings
Table 114. Coherus Bioscience Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 115. Stada Arzneimittel AG Corporate Summary
Table 116. Stada Arzneimittel AG Biosimilars Product Offerings
Table 117. Stada Arzneimittel AG Biosimilars Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 118. Biosimilars Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 119. Global Biosimilars Capacity Market Share of Key Manufacturers, 2020-2022
Table 120. Global Biosimilars Production by Region, 2017-2022 (K MT)
Table 121. Global Biosimilars Production by Region, 2023-2028 (K MT)
Table 122. Biosimilars Market Opportunities & Trends in Global Market
Table 123. Biosimilars Market Drivers in Global Market
Table 124. Biosimilars Market Restraints in Global Market
Table 125. Biosimilars Raw Materials
Table 126. Biosimilars Raw Materials Suppliers in Global Market
Table 127. Typical Biosimilars Downstream
Table 128. Biosimilars Downstream Clients in Global Market
Table 129. Biosimilars Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biosimilars Segment by Type
Figure 2. Biosimilars Segment by Application
Figure 3. Global Biosimilars Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biosimilars Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biosimilars Revenue, 2017-2028 (US$, Mn)
Figure 7. Biosimilars Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Biosimilars Revenue in 2021
Figure 9. By Type - Global Biosimilars Sales Market Share, 2017-2028
Figure 10. By Type - Global Biosimilars Revenue Market Share, 2017-2028
Figure 11. By Type - Global Biosimilars Price (USD/MT), 2017-2028
Figure 12. By Application - Global Biosimilars Sales Market Share, 2017-2028
Figure 13. By Application - Global Biosimilars Revenue Market Share, 2017-2028
Figure 14. By Application - Global Biosimilars Price (USD/MT), 2017-2028
Figure 15. By Region - Global Biosimilars Sales Market Share, 2017-2028
Figure 16. By Region - Global Biosimilars Revenue Market Share, 2017-2028
Figure 17. By Country - North America Biosimilars Revenue Market Share, 2017-2028
Figure 18. By Country - North America Biosimilars Sales Market Share, 2017-2028
Figure 19. US Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Biosimilars Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Biosimilars Sales Market Share, 2017-2028
Figure 24. Germany Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 25. France Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Biosimilars Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Biosimilars Sales Market Share, 2017-2028
Figure 33. China Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 37. India Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Biosimilars Revenue Market Share, 2017-2028
Figure 39. By Country - South America Biosimilars Sales Market Share, 2017-2028
Figure 40. Brazil Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Biosimilars Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Biosimilars Sales Market Share, 2017-2028
Figure 44. Turkey Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Biosimilars Revenue, (US$, Mn), 2017-2028
Figure 48. Global Biosimilars Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Biosimilars by Region, 2021 VS 2028
Figure 50. Biosimilars Industry Value Chain
Figure 51. Marketing Channels
